Search

everythinglearnresearchcommunity

for

Search:↓

Combining red LED therapy with beta-carotene is more effective for treating photoaging than red LED therapy alone.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Etanercept effectively treated a severe skin condition when other treatments failed.

Minoxidil sulfate gel can be used to treat hair loss.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

The gel with apocynin-loaded nanoparticles shows promise for treating rheumatoid arthritis.

The gel form of substance Y is the most effective for treating hair loss.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Erlotinib can cause excessive eyelash growth.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Some elderly men had healing problems after using imiquimod and diclofenac for skin conditions on their scalps.